作者对“致编辑的信:人感染猴痘和非典型暴发”的回应

The author’s response to "Letter to editor:human monkeypox and the atypical outbreak"

非常感谢Mungmunpuntipantip R和Wiwanitkit V对本人撰写的“知往鉴今:人感染猴痘史及其非同寻常的2022年多国暴发疫情”[1]的关注和评论。正如他们所言,2022年人感染猴痘(human monkeypox,HMPX)疫情中,病例的临床表现与既往报告也存在相当大的差异,这增强了此次疫情“非同寻常”的特点。

I really appreciate the comment from Mungmunpuntipantip R and Wiwanitkit V on my recent published article"Learning from the past:the history of human monkeypox and the atypical multi country outbreak in 2022"[1].As the comment,the clinical manifestations of the human monkeypox(HMPX)cases in the 2022 outbreak were quite different from the previous reports,which enhanced the"atypical"characteristics of this epidemic.